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Abstract
Background: Patients with essential tremor (ET) have an increased prevalence of hearing loss, and depression is a confounding issue for both conditions. We
assessed hearing loss in non-depressed ET patients and controls using a questionnaire and audiometric tests.
Methods: The study included 34 patients with ET and 45 volunteers were included. Both groups were asked if they had hearing loss, and pure tone audiometry,
speech recognition threshold, tympanogram, short increment sensitivity index (SISI), tone decay, and otoacoustic emission audiological tests were conducted.
Results: Seventeen subjects (50.0%) in the patient group answered ‘‘yes’’ to the question ‘‘Do you have hearing loss?’’ compared to one (2.2%) subject in the
control group (p,0.001). The tone decay values of the right ear at 4,000 Hz were higher in the patient group. The number of subjects in which the otoacoustic
emissions could not be obtained in the right ear was higher in the ET patients (p50.005).
Discussion: The results support the presence of a cochlear pathology in ET and may indicate that ET and sensorineural hearing loss may be components of a
common disease process.
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Introduction
Essential tremor (ET) is one of the most common neurological
diseases in adulthood.1 One epidemiological study reported that
prevalence is between 0.4% and 3.9%.2
Hearing loss particularly affects the elderly; the prevalence of
hearing loss has been reported as 46% among American adults older
than 48 years of age.3
Although ET and hearing loss are two different disorders that are
frequently seen together, their association has not been extensively
investigated. Ondo et al. performed detailed audiological tests in
patients with ET and found that they had higher rates of sensorineural
hearing loss and hearing loss-related disability.4 Benito-Leo´n and
colleagues diagnosed ET in 30% of patients with hearing loss.5 Finally,
Balaban et al. measured sensorineural hearing loss in ET patients by
performing otoacoustic emission (OAE), and brainstem auditory
evoked Response (BAER) was thought to be related to cochlear
pathology.6
Hearing loss can negatively impact quality of life as it has adverse
effects on physical, cognitive, emotional, behavioral and social
functions. One study associated even mild hearing loss with significant
disability.7
Depressive symptoms are rather common among individuals with
ET and may even be a component of the disease.8 It was reported that
these symptoms negatively affect quality of life and that the treatment
of ET was difficult due to low drug therapy compliance among
depressive patients, thereby increasing the tremor-related disability.9
The aim of this case-control study was to assess the frequency of
sensorineural hearing loss in ET patients without depression and to
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document the quality and quantity of hearing loss using audiometric
tests.
Methods
Forty-six ET patients and 46 volunteers who presented to our
neurology department between January 2006 and March 2007 were
included in the study after approval was granted by the institutional
ethics committee. The control group consisted of subjects with low
back and leg pain whose neurological examinations were normal. The
data were collected prospectively. We included 46 consecutive patients
who met the ‘‘definite ET’’ criteria defined by the Movement
Disorders Society committee10 and asked each patient about disease
duration. Tremor severity was assessed by a clinical rating scale for
tremor (CRST),11 and tremor-induced disability was assessed by an
activities of daily living (ADL) self questionnaire.12 The Hamilton
Depression Scale (HDS)13 was applied to both groups, and subjects
who scored 8 or more points were excluded from the study. None of
the ET patients were taking any medications that could worsen
tremor, including antidepressants.
The question ‘‘Do you have hearing loss?’’ was asked to both
groups, and the answers were recorded as ‘‘yes’’ or ‘‘no.’’ An
otorhinolaryngology resident used an otoscope to examine the
subjects’ external auditory canals, and those with any abnormal
findings were excluded.
Sensorineural hearing loss is due to injury of the nerve pathways
that extend from the cochlea or inner ear to the brain. The
audiological tests performed to detect sensorineural hearing loss were
as follows:
1) Pure Tone Audiometry (PTA): Determines the lowest tone
frequency that both ears may hear at different frequencies
(averages of 500, 1,000, 2,000, 4,000 Hz frequencies). In our
study, subjects who had a threshold value above 20 dB were
considered to have hearing loss.
2) Speech Recognition Threshold (SRT): This test begins with the
administrator reading bisyllabic words starting at a level that the
patient can hear easily. The volume was lowered as the patient
repeated the words, and the lowest level at which the patient was
able to repeat three of the five words was determined as the
threshold value of speech recognition. A difference greater than
10 dB from the PTA was considered abnormal.
3) Short Increment Sensitivity Index (SISI): Reveals the ability of
the subject to discriminate 1 dB increases by adding 20 dB to
500, 1,000, 2,000, and 4000 Hz threshold values. Values above
25% were considered abnormal.
4) Tone Decay: This test is based on the principle that a tone
played continuously by adding 5 dB on 500, 1,000, 2,000 and
4,000 Hz threshold values cannot be heard after a while. Levels
above ‘0’ were considered abnormal.
5) Transient Otoacoustic Emission: This technique records the
sound produced by the inner ear through the external auditory
canal. Its absence was considered abnormal.
6) Measurement of middle ear pressure by tympanometry: Values
between 2150 and +100 daPa were accepted as normal.
Patients who had values outside of this range were considered to
have a middle ear pathology and were excluded from the study.
Ten patients and one control subject were excluded from the study
because they had depression, and two patients were excluded from the
study because they had middle ear pathologies according to
tympanometry results. Ultimately, 34 patients and 45 controls were
included in the study.
Statistical analysis
Kolmogorov-Smirnov tests were used to test data normality.
Continuous variables meeting the normality assumption are presented
as mean ¡ standard deviation, otherwise median (minimum–
maximum) values were given. Independent sample t-tests were used
to compare two groups for continuous variables meeting the normality
assumption. Mann-Whitney U-tests were carried out for variables not
meeting the normality assumption. Categorical variables are expressed
as counts and percentages. Comparisons between the two groups were
performed with Pearson Chi-square tests for categorical variables. A p
value less than 0.05 was considered significant.
Results
The median age of the patients (18 females, 16 males) was 57.5 years
(range 18–82). The median duration of illness was 12.0 years (range 1–50).
The median age of the controls (25 females, 20 males) was 60.0 (range 18–
80). There was no significant difference between the patient and control
groups in terms of age or sex (p50.638 and p50.998, respectively).
The median CRST score was 7.0 (range 2–22) and that of ADL was
38.0 (range 25–61).
While 17 subjects (50.0%) in the patient group answered ‘‘yes’’ and
17 answered ‘‘no’’ to the question ‘‘Do you have hearing loss?,’’ only
one subject (2.2%) in the control group answered ‘‘yes.’’ The difference
between the two groups was statistically significant (p,0.001).
The results of the audiological tests of the patients and controls are
presented in Tables 1–4.
There was no significant difference between the two groups with
regard to PTA and SRT values and SISI test results. The tone decay
mean values in 4,000 Hz of the patients’ right ear were significantly
higher, and the number of patients without OAE was significantly
higher than in the control group.
The number of the patients above 65 years old was 10 (29.41%)
compared to 15 (33.33%) in the control group. The audiological test
results of the two groups are compared in Table 5.
The PTA and tone decay scores in high frequencies were statistically
higher in the older patient group.
Discussion
The concept that ET is a more complex and heterogeneous
degenerative disease rather than a single modality is gradually
becoming widespread.14 However, certain accompanying neurological
signs have recently been reported in many ET patients, such as
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cogwheeling, difficulty in tandem gait, hypermetria, and vestibulo-
ocular disturbances.15
In this study, we aimed to measure the prevalence of sensorineural
hearing loss (accepted as a part of the disease) in ET patients without
depression.
Audiologic tests are the gold standard to detect hearing loss, but the
question ‘‘Do you have hearing loss?’’ was also shown to be quite
sensitive and specific for the detection of hearing loss when compared
with PTA results.16 In our study, 17 out of 34 (50.0%) ET patients
reported hearing loss compared to just one (2.2%) subject in the
control group, which confirmed that ET patients declared hearing loss
even without performing audiologic testing.
PTA is a subjective test that determines the minimum tone
frequency at which both ears can hear at various frequencies. In our
study, no significant difference was found between the patient and
control groups. The SRT measures subjects’ abilities to hear and
understand speech.17 If the difference from the pure tone average is
more than 10 dB, retrocochlear pathologies or hearing loss that is not
organic should be suspected. In our study, the difference between the
pure tone average values and SRT values was not more than 7 dB for
both ears in both groups. Furthermore, no significant difference was
found between the groups’ mean values. Although both tests indicate
the presence of hearing loss, they do not discriminate whether it
originates from cochlear or retrocochlear areas.
SISI test scores tend to be low at 250 and 500 Hz frequencies (0–
20%); suspicious at 1,000 Hz (40–60%); and very high at 2,000, 3,000,
and 4,000 Hz frequencies (80–100%). Thus, the SISI test is quite
successful for indicating cochlear injury, particularly at high frequen-
cies.18 We did not observe a significant difference between the SISI test
scores of the two groups, even at the highest frequency.
The tone decay test measures the hearing adaptation phenomenon,
which indicates variability in the sensitivity of the hearing system in
response to a constant stimulus.19 Tone decay values vary largely in
subjects with cochlear loss and may reach 30 dB.20 Patients with
normal or mild hearing loss at low frequencies may have high tone
decay values at high frequencies.21 Consistent with the literature, we
found that the pure tone averages showed mild hearing loss, and the
tone decay test values were found to be significantly higher for the
right ears of the patients at 4,000 Hz compared to the control group.
When young patients were excluded, there was a significant
difference between the PTA scores in subjects older than 65 in both
groups. In addition, there was a significant difference of tone decay test
Table 1. Comparison of the Right and Left Ear PTA and SRT Results in Patients and Controls
Test Ear Patients Controls p Value
PTA Right 21 (3–58) 20 (7–42) 0.466
Left 19 (5–57) 18 (5–42) 0.644
SRT Right 22.5 (10–58) 20 (5–45) 0.397
Left 20 (10–58) 20 (5–45) 0.397
The scores are expressed as median score (minimum–maximum). Abbreviations: PTA, Pure Tone Audiometry; SRT, Speech Recognition Threshold.
Table 2. Comparison of the Right and Left Ear SISI Test Averages in Patients and Controls
Test Ear Patients Controls p Value
SISI 500 Right 0.0 (0–0) 0.0 (0–0) 1.000
Left 0.0 (0–0) 0.0 (0–0) 1.000
SISI 1,000 Right 0 (0–20) 0 (0–45) 0.446
Left 0 (0–65) 0 (0–65) 0.197
SISI 2,000 Right 0 (0–85) 0 (0–80) 0.210
Left 0 (0–85) 0 (0–80) 0.210
SISI 4,000 Right 0 (0–100) 0 (0–90) 0.090
Left 0 (0–100) 0 (0–95) 0.148
The scores are expressed as median score (minimum–maximum).
Abbreviation: SISI, Short Increment Sensitivity Index.
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scores of the right ear at 2,000 Hz and both ears at 4,000 Hz. As a
result, the hearing test scores of older ET patients were significantly
worse, which is consistent with a previous study.4
OAEs are present in 100% of subjects with normal hearing, and they
indicate normal cochlear function.22 In particular, the external ciliary
cells (amplifier of the cochlea) must work regularly for OAE
emergence.23 The lack of OAE indicates the presence of sensorineural
hearing loss. We could not obtain OAE in the right and left ears of
38.2% and 32.3% of patients and 13.3% and 15.5% of control subjects.
In conclusion, the percentage of the patients in whom OAE could not be
obtained in the right ear was significantly higher than in the control
group. These results support the hypothesis of an increased prevalence
of sensorineural hearing loss in ET patients compared to controls.
Although the pathogenesis of ET is controversial, the cerebellum is
known to play an important role.24 Recent postmortem studies have
indicated a reduced number of Purkinje cells in the cerebella of ET
patients without Lewy bodies.25 Moreover, cerebello-thalamo-cortical
pathway impairment is hypothesized in ET.26 One of the proposed
explanations regarding the relationship between ET and hearing loss
involves the passage of sound stimuli through the thalamus.4 An
abnormal stimulus of the ventral thalamus is also suspected in ET.
Ondo et al. proposed that physiological perturbation in the ventral
thalamus could account for both tremor and hearing loss.4
In our study, tone decay tests at high frequencies were significantly
higher in ET patients compared to the control subjects. In addition, the
number of subjects in whom OAEs could not be obtained was
significantly higher for ET patients. Collectively, these findings support
cochlear pathologies. Therefore, another possibility underlying the
coexistence of ET and hearing loss is related to connexin proteins.
Connexin genes encode the subunits of gap junction proteins, which
enable rapid transport of ions, secondary messengers, and small
metabolites for fast intercellular communication.27 A study of patients
who had Charcot-Marie-Tooth disease, an X-linked inherited condition
associated with connexin 32 mutation, reported that additional findings
such as sensorineural hearing loss and tremor could accompany the
clinical manifestations.28 While the relationship between cochlear
hearing loss and ET could be associated with connexin mutations,
more studies are needed to clearly demonstrate this link.
ET is accepted to be a neurodegenerative cerebellar disorder.29 A
few studies have reported on the relationship between hearing loss and
Table 3. Comparison of the Right and Left Ear Tone Decay Test Averages in Patients and Controls
Test Ear Patients Controls p Value
Tone Decay 500 Right 0.0 (0–0) 0.0 (0–0) 1.000
Left 0.0 (0–0) 0.0 (0–0) 1.000
Tone Decay 1,000 Right 0 (0–5) 0.0 (0–0) 0.250
Left 0 (0–5) 0 (0–5) 0.256
Tone Decay 2,000 Right 0 (0–15) 0 (0–5) 0.108
Left 0 (0–15) 0 (0–10) 0.136
Tone Decay 4,000 Right 0 (0–15) 0 (0–10) 0.005
Left 0 (0–20) 0 (0–15) 0.108
The scores are expressed as median score (minimum–maximum).
Table 4. Comparison of the Right and Left Ear OAE Results in Patients and Controls
Patients Controls p Value
n (%) n (%)
Right OAE + 21 (61.3%) 39 (86.7%) 0.022
2 13 (38.7%) 6 (13.3%)
Left OAE + 23 (67.7%) 38 (84.4%) 0.136
2 11 (32.3%) 7 (15.6%)
Abbreviation: OAE, Otoacoustic Emission.
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other cerebellar degenerative disorders. Ikeda et al. reported that
sensorineural hearing loss in spinocerebellar ataxia (SCA) 36 was due
to inner ear or peripheral auditory system pathology and described a
positive correlation between PTA values and disease duration.30
In conclusion, we performed SISI, tone decay, and OAE tests to
assess cochlear pathology in both ET patient and control groups.
Depressed subjects were excluded to avoid possible negative effects on
ET findings and hearing test results. The significantly higher mean
values of the tone decay test in high frequencies and the higher
number of patients without OAEs indicate the presence of cochlear
pathology in subjects with ET and support the findings of previous
studies. Although our results were only modestly abnormal when
compared to controls, this may be due to the relatively mild tremor
and young age of the ET population. Collectively, these results indicate
that there may be a common factor in the pathogeneses of ET and
sensorineural hearing loss, and further molecular genetic studies will
shed light on the relationship between these two diseases.
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